FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2610271111> ?p ?o ?g. }

• W2610271111 endingPage "e0175721" @default.
• W2610271111 startingPage "e0175721" @default.
• W2610271111 abstract "Background Public health programs to prevent invasive meningococcal disease (IMD) with monovalent serogroup C meningococcal conjugate vaccine (MCV-C) and quadrivalent meningococcal conjugate vaccines (MCV-4) in infancy and adolescence vary across Canadian provinces. This study evaluated the cost-effectiveness of various vaccination strategies against IMD using current and anticipated future pricing and recent epidemiology. Methods A cohort model was developed to estimate the clinical burden and costs (CAN$2014) of IMD in the Canadian population over a 100-year time horizon for three strategies: (1) MCV-C in infants and adolescents (MCV-C/C); (2) MCV-C in infants and MCV-4 in adolescents (MCV-C/4); and (3) MCV-4 in infants (2 doses) and adolescents (MCV-4/4). The source for IMD incidence was Canadian surveillance data. The effectiveness of MCV-C was based on published literature. The effectiveness of MCV-4 against all vaccination regimens was assumed to be the same as for MCV-C regimens against serogroup C. Herd effects were estimated by calibration to estimates reported in prior analyses. Costs were from published sources. Vaccines prices were projected to decline over time reflecting historical procurement trends. Results Over the modeling horizon there are a projected 11,438 IMD cases and 1,195 IMD deaths with MCV-C/C; expected total costs are $597.5 million. MCV-C/4 is projected to reduce cases of IMD by 1,826 (16%) and IMD deaths by 161 (13%). Vaccination costs are increased by $32 million but direct and indirect IMD costs are projected to be reduced by $46 million. MCV-C/4 is therefore dominant vs. MCV-C/C in the base case. Cost-effectiveness of MCV-4/4 was $111,286 per QALY gained versus MCV-C/4 (2575/206 IMD cases/deaths prevented; incremental costs $68 million). Conclusions If historical trends in Canadian vaccines prices continue, use of MCV-4 instead of MCV-C in adolescents may be cost-effective. From an economic perspective, switching to MCV-4 as the adolescent booster should be considered." @default.
• W2610271111 created "2017-05-12" @default.
• W2610271111 creator A5001188908 @default.
• W2610271111 creator A5005456406 @default.
• W2610271111 creator A5014353115 @default.
• W2610271111 creator A5017672216 @default.
• W2610271111 creator A5027897513 @default.
• W2610271111 creator A5049016427 @default.
• W2610271111 creator A5086060594 @default.
• W2610271111 creator A5088517889 @default.
• W2610271111 date "2017-05-04" @default.
• W2610271111 modified "2023-09-27" @default.
• W2610271111 title "Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada" @default.
• W2610271111 cites W1182185477 @default.
• W2610271111 cites W15646161 @default.
• W2610271111 cites W1990237742 @default.
• W2610271111 cites W2007885895 @default.
• W2610271111 cites W2018560622 @default.
• W2610271111 cites W2047369361 @default.
• W2610271111 cites W2047639252 @default.
• W2610271111 cites W2049865589 @default.
• W2610271111 cites W2073559015 @default.
• W2610271111 cites W2080182958 @default.
• W2610271111 cites W2112537214 @default.
• W2610271111 cites W2139793607 @default.
• W2610271111 cites W2142373856 @default.
• W2610271111 cites W2143416879 @default.
• W2610271111 cites W2150740150 @default.
• W2610271111 cites W2157398791 @default.
• W2610271111 cites W2160879811 @default.
• W2610271111 cites W2162319245 @default.
• W2610271111 cites W2167186265 @default.
• W2610271111 cites W2168091352 @default.
• W2610271111 cites W2188298813 @default.
• W2610271111 cites W2314221612 @default.
• W2610271111 cites W4300943706 @default.
• W2610271111 doi "https://doi.org/10.1371/journal.pone.0175721" @default.
• W2610271111 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5417484" @default.
• W2610271111 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28472165" @default.
• W2610271111 hasPublicationYear "2017" @default.
• W2610271111 type Work @default.
• W2610271111 sameAs 2610271111 @default.
• W2610271111 citedByCount "10" @default.
• W2610271111 countsByYear W26102711112018 @default.
• W2610271111 countsByYear W26102711112019 @default.
• W2610271111 countsByYear W26102711112021 @default.
• W2610271111 countsByYear W26102711112023 @default.
• W2610271111 crossrefType "journal-article" @default.
• W2610271111 hasAuthorship W2610271111A5001188908 @default.
• W2610271111 hasAuthorship W2610271111A5005456406 @default.
• W2610271111 hasAuthorship W2610271111A5014353115 @default.
• W2610271111 hasAuthorship W2610271111A5017672216 @default.
• W2610271111 hasAuthorship W2610271111A5027897513 @default.
• W2610271111 hasAuthorship W2610271111A5049016427 @default.
• W2610271111 hasAuthorship W2610271111A5086060594 @default.
• W2610271111 hasAuthorship W2610271111A5088517889 @default.
• W2610271111 hasBestOaLocation W26102711111 @default.
• W2610271111 hasConcept C106192422 @default.
• W2610271111 hasConcept C107130276 @default.
• W2610271111 hasConcept C112930515 @default.
• W2610271111 hasConcept C120665830 @default.
• W2610271111 hasConcept C121332964 @default.
• W2610271111 hasConcept C126322002 @default.
• W2610271111 hasConcept C159654299 @default.
• W2610271111 hasConcept C187212893 @default.
• W2610271111 hasConcept C203014093 @default.
• W2610271111 hasConcept C22070199 @default.
• W2610271111 hasConcept C2776645655 @default.
• W2610271111 hasConcept C2778458888 @default.
• W2610271111 hasConcept C2779583294 @default.
• W2610271111 hasConcept C2780454893 @default.
• W2610271111 hasConcept C2780801004 @default.
• W2610271111 hasConcept C2908647359 @default.
• W2610271111 hasConcept C3019080777 @default.
• W2610271111 hasConcept C523546767 @default.
• W2610271111 hasConcept C54355233 @default.
• W2610271111 hasConcept C61511704 @default.
• W2610271111 hasConcept C71924100 @default.
• W2610271111 hasConcept C86803240 @default.
• W2610271111 hasConcept C99454951 @default.
• W2610271111 hasConceptScore W2610271111C106192422 @default.
• W2610271111 hasConceptScore W2610271111C107130276 @default.
• W2610271111 hasConceptScore W2610271111C112930515 @default.
• W2610271111 hasConceptScore W2610271111C120665830 @default.
• W2610271111 hasConceptScore W2610271111C121332964 @default.
• W2610271111 hasConceptScore W2610271111C126322002 @default.
• W2610271111 hasConceptScore W2610271111C159654299 @default.
• W2610271111 hasConceptScore W2610271111C187212893 @default.
• W2610271111 hasConceptScore W2610271111C203014093 @default.
• W2610271111 hasConceptScore W2610271111C22070199 @default.
• W2610271111 hasConceptScore W2610271111C2776645655 @default.
• W2610271111 hasConceptScore W2610271111C2778458888 @default.
• W2610271111 hasConceptScore W2610271111C2779583294 @default.
• W2610271111 hasConceptScore W2610271111C2780454893 @default.
• W2610271111 hasConceptScore W2610271111C2780801004 @default.
• W2610271111 hasConceptScore W2610271111C2908647359 @default.
• W2610271111 hasConceptScore W2610271111C3019080777 @default.
• W2610271111 hasConceptScore W2610271111C523546767 @default.

• next